ZYMEWORKS DL-00001
Zymeworks Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID). Its therapeutic platforms and fully integrated drug development engine provides the flexibility and compatibility to precisely engineer and develop highly differentiated antibody-based therapeutic candidates. … Read more
Market Cap & Net Worth: ZYMEWORKS DL-00001 (ZA8)
ZYMEWORKS DL-00001 (F:ZA8) has a market capitalization of $1.54 Billion (€1.50 Billion) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #5777 globally and #603 in its home market, demonstrating a -2.91% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ZYMEWORKS DL-00001's stock price €20.00 by its total outstanding shares 74836534 (74.84 Million).
ZYMEWORKS DL-00001 Market Cap History: 2018 to 2026
ZYMEWORKS DL-00001's market capitalization history from 2018 to 2026. Data shows growth from $757.42 Million to $1.54 Billion (8.78% CAGR).
ZYMEWORKS DL-00001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ZYMEWORKS DL-00001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ZA8 by Market Capitalization
Companies near ZYMEWORKS DL-00001 in the global market cap rankings as of March 19, 2026.
Key companies related to ZYMEWORKS DL-00001 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
ZYMEWORKS DL-00001 Historical Marketcap From 2018 to 2026
Between 2018 and today, ZYMEWORKS DL-00001's market cap moved from $757.42 Million to $ 1.54 Billion, with a yearly change of 8.78%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.54 Billion | -9.91% |
| 2025 | €1.71 Billion | +59.71% |
| 2024 | €1.07 Billion | +46.44% |
| 2023 | €729.15 Million | +32.38% |
| 2022 | €550.78 Million | -45.02% |
| 2021 | €1.00 Billion | -65.18% |
| 2020 | €2.88 Billion | -8.21% |
| 2019 | €3.13 Billion | +313.79% |
| 2018 | €757.42 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of ZYMEWORKS DL-00001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.54 Billion USD |
| MoneyControl | $1.54 Billion USD |
| MarketWatch | $1.54 Billion USD |
| marketcap.company | $1.54 Billion USD |
| Reuters | $1.54 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.